Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer. [electronic resource]
Producer: 20190705Description: 933-937 p. digitalISSN:- 1537-453X
- Adenocarcinoma -- drug therapy
- Angiogenesis Inhibitors -- adverse effects
- Bevacizumab -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Female
- Fistula -- diagnosis
- Follow-Up Studies
- Humans
- Hypoalbuminemia -- chemically induced
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Prognosis
- Salvage Therapy
- Survival Rate
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.